It is now possible to combine antigens with specific adjuvant systems to create more effective vaccines.
Philippe Monteyne, MD, PhD,
Advertisement
Philippe Monteyne, MD, PhD, is the senior vice president of global vaccine development all at GlaxoSmithKline Biologicals
Articles by Philippe Monteyne, MD, PhD,
Advertisement
Latest Updated Articles
Addressing Unmet Medical Needs Through Tailored Vaccine Design: The Importance of Adjuvant SystemsPublished: October 1st 2009 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
2
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
3
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
4
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
5
